CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rugge, M.
Right arrow Articles by Shiao, Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rugge, M.
Right arrow Articles by Shiao, Y. H.

Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 3 171-176, Copyright © 1997 by American Association for Cancer Research


ARTICLES

p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy

M Rugge, D Bovo, G Busatto, AR Parenti, S Fawzy, M Guido, E Ancona, V Ninfo, A Ruol and YH Shiao
Cattedra di Istochimica and Immunoistochimica Patologica, University of Padova, Italy. rugge@ipdunidx.unipd.it

Geographic differences in exposure to suspected carcinogens have been identified in esophageal carcinogenesis, and both p53 alterations and human papillomavirus (HPV) infection have been reported in esophageal squamous carcinoma (ESC) from high-risk areas, including China and South Africa. The status of p53 alterations and HPV infection in ESC has not been determined in northern Italy, where the incidence of ESC is low. Formalin-fixed paraffin-embedded esophageal samples containing normal, dysplastic, and carcinomatous tissue from 18 patients were examined for p53 protein accumulation with immunohistochemistry, p53 mutation (exons 5-8) with PCR-single-strand conformation polymorphism analysis and DNA sequencing, and HPV infection with PCR using general primers to amplify the L1 gene. Accumulation of p53 protein was observed in both precancerous and carcinomatous lesions. p53 mutations were rare in dysplastic lesions but were detected in 9 of 18 carcinomas, a finding consistent with reports from other geographic areas. Examination of the p53 mutation spectrum revealed no hot spot mutation. In contrast, HPV was not found in any of these 18 cases. This is consistent with the findings from other low ESC risk areas in which HPV infection may not play a crucial role in esophageal oncogenesis, whereas the high risk of ESC in China and South Africa may be attributed to frequent HPV infection.


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
K J Syrjanen
HPV infections and oesophageal cancer
J. Clin. Pathol., October 1, 2002; 55(10): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
M Rugge, Y-H Shiao, G Busatto, M Cassaro, C Strobbe, V M Russo, G Leo, A R Parenti, A Scapinello, P Arslan, et al.
The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location
Mol. Pathol., August 1, 2000; 53(4): 207 - 210.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.